These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 32079466)
1. The role of molecular and imaging biomarkers in the evaluation of inflammation in oncology. Canese R; Bazzocchi A; Blandino G; Carpinelli G; De Nuccio C; Gion M; Moretti F; Soricelli A; Spessotto P; Iorio E Int J Biol Markers; 2020 Feb; 35(1_suppl):5-7. PubMed ID: 32079466 [No Abstract] [Full Text] [Related]
2. The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part I). Vaidya T; Agrawal A; Mahajan S; Thakur MH; Mahajan A Mol Diagn Ther; 2019 Feb; 23(1):1-26. PubMed ID: 30411216 [TBL] [Abstract][Full Text] [Related]
3. The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part II). Vaidya T; Agrawal A; Mahajan S; Thakur MH; Mahajan A Mol Diagn Ther; 2019 Feb; 23(1):27-51. PubMed ID: 30387041 [TBL] [Abstract][Full Text] [Related]
4. Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy. Zhu L; Staley C; Kooby D; El-Rays B; Mao H; Yang L Cancer Lett; 2017 Mar; 388():139-148. PubMed ID: 27916607 [TBL] [Abstract][Full Text] [Related]
5. Immuno-PET of cancer: a revival of antibody imaging. Boerman OC; Oyen WJ J Nucl Med; 2011 Aug; 52(8):1171-2. PubMed ID: 21764784 [No Abstract] [Full Text] [Related]
6. Targeting P-Selectin Adhesion Molecule in Molecular Imaging: P-Selectin Expression as a Valuable Imaging Biomarker of Inflammation in Cardiovascular Disease. Perkins LA; Anderson CJ; Novelli EM J Nucl Med; 2019 Dec; 60(12):1691-1697. PubMed ID: 31601694 [TBL] [Abstract][Full Text] [Related]
7. Molecular imaging biomarkers for oncology clinical trials. Mankoff DA; Pryma DA; Clark AS J Nucl Med; 2014 Apr; 55(4):525-8. PubMed ID: 24614222 [TBL] [Abstract][Full Text] [Related]
9. Recent advances in molecular imaging biomarkers in cancer: application of bench to bedside technologies. van der Meel R; Gallagher WM; Oliveira S; O'Connor AE; Schiffelers RM; Byrne AT Drug Discov Today; 2010 Feb; 15(3-4):102-14. PubMed ID: 20035896 [TBL] [Abstract][Full Text] [Related]
10. Molecular imaging of inflammation/infection: nuclear medicine and optical imaging agents and methods. Signore A; Mather SJ; Piaggio G; Malviya G; Dierckx RA Chem Rev; 2010 May; 110(5):3112-45. PubMed ID: 20415479 [No Abstract] [Full Text] [Related]
11. Molecular Imaging of Biomarkers in Breast Cancer. Ulaner GA; Riedl CC; Dickler MN; Jhaveri K; Pandit-Taskar N; Weber W J Nucl Med; 2016 Feb; 57 Suppl 1(Suppl 1):53S-9S. PubMed ID: 26834103 [TBL] [Abstract][Full Text] [Related]
12. Imaging requirements for personalized medicine: the oncologists point of view. Kruse V; Belle SV; Cocquyt V Curr Pharm Des; 2014; 20(14):2234-49. PubMed ID: 24025098 [TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment and systemic disease: a dual target in medical oncology (also in the case of biomarkers). Melichar B Clin Chem Lab Med; 2017 Oct; 55(12):1813-1816. PubMed ID: 29040065 [No Abstract] [Full Text] [Related]
14. Metabolic PET Imaging in Oncology. Sai KKS; Zachar Z; Bingham PM; Mintz A AJR Am J Roentgenol; 2017 Aug; 209(2):270-276. PubMed ID: 28463521 [TBL] [Abstract][Full Text] [Related]